Curriculum Vitae
Inês Francisca Gouveia Vasconcelos
Identification
Personal identification
- Full name
- Inês Francisca Gouveia Vasconcelos
Citation names
- Vasconcelos, Inês
Author identifiers
- Ciência ID
- 3713-4FB7-3446
- ORCID iD
- 0000-0002-4870-9946
Knowledge fields
- Medical and Health Sciences - Basic Medicine - Physiology
- Medical and Health Sciences - Clinical Medicine - Cardiac and Cardiovascular Systems
Languages
| Language | Speaking | Reading | Writing | Listening | Peer-review |
|---|---|---|---|---|---|
| Portuguese (Mother tongue) | |||||
| English | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) |
| Spanish; Castilian | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) |
| French | Beginner (A1) | Elementary (A2) | Beginner (A1) | Elementary (A2) | Beginner (A1) |
Education
| Degree | Classification | |
|---|---|---|
|
2022 - 2026
Ongoing
|
Medicina (Mestrado integrado)
Universidade do Minho Escola de Medicina, Portugal
|
|
|
2021 - 2025
Ongoing
|
Ciências Cardiovasculares (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
|
|
|
2019/09 - 2021/12
Concluded
|
Bioquímica (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
"Role of Urocortin-2 in Heart Failure with preserved Ejection Fraction - pathophysiological and therapeutic implications" (THESIS/DISSERTATION)
|
18 |
|
2016 - 2019
Concluded
|
Bioquímica (Licenciatura)
Universidade do Porto Faculdade de Ciências, Portugal
"Exploring a mucosal vaccination approach against Neospora caninum infection" (THESIS/DISSERTATION)
|
15 |
Affiliation
Science
| Category Host institution |
Employer | |
|---|---|---|
| 2020 - Current | Researcher (Research) | Universidade do Porto Faculdade de Medicina, Portugal |
Projects
Grant
| Designation | Funders | |
|---|---|---|
| 2023 - Current | Relaxin-2 and Pulmonary Arterial Hypertension: pathophysiological role and therapeutic potential
2022.08921.PTDC
Researcher
|
Ongoing
|
Other
| Designation | Funders | |
|---|---|---|
| 2020 - Current | The role of urocortin-2 in in heart failure with preserved ejection fraction
-
Researcher
Universidade do Porto Faculdade de Medicina, Portugal
|
Outputs
Publications
| Book chapter |
|
| Conference abstract |
|
| Journal article |
|
Activities
Oral presentation
| Presentation title | Event name Host (Event location) |
|
|---|---|---|
| 2024/04 | Urocortin-2 as a novel biomarker of clinical deterioration in HFpEF: A prospective cohort study. | Congresso Português de Cardiologia |
| 2022/11 | Urocortin-2 and its effects in an animal model of metabolic syndrome. | 1st Conference of the Doctoral Program in Metabolism - Clinical and Experimental
(Porto, Portugal)
|
| 2022/11 | Therapeutic implications of urocortin-2 in Heart Failure with preserved Ejection Fraction. | Congresso Internacional da Sociedade Portuguesa de Fisiologia
(Coimbra, Portugal)
|
| 2022/08 | Pathophysiological and therapeutic implications of urocortin-2 in heart failure with preserved ejection fraction. | ESC Congress
(Barcelona, Spain)
|
| 2022/08 | Therapeutic effects of nebulization- based delivery of anti-miR-146a in experimental pulmonary arterial hypertension. | ESC Congress
(Barcelona, Spain)
|
| 2022/06 | Therapeutic effects of nebulization- based delivery of anti-miR-146a in experimental pulmonary arterial hypertension. | 31st European Meeting on Hypertension and Cardiovascular Protection
(Athens, Greece)
|
| 2022/05 | The role of miR-146a in the pathophysiology of pulmonary arterial hypertension - therapeutic implications. | Heart Failure Congress
(Madrid, Spain)
|
| 2022/05 | Therapeutic effects of urocortin-2 in Heart Failure with preserved Ejection Fraction. | Heart Failure Congress
(Madrid, Spain)
|
| 2022/04 | Therapeutic effect of Urocortin-2 in Heart Failure with Preserved Ejection Fraction. | Congresso Português de Cardiologia 2022
(Albufeira, Portugal)
|
| 2022/04 | Therapeutic effects of nebulization- based delivery of anti-miR-146a in experimental pulmonary arterial hypertension. | Congresso Português de Cardiologia
(Albufeira, Portugal)
|
| 2022/03 | Pathophysiological and therapeutic implications of Urocortin-2 in Heart Failure with Preserved Ejection Fraction. | AIMS meeting 2022 - Annual International (bio)Medical Students Meeting
(Lisboa, Portugal)
|
| 2021/09 | Pathophysiological and therapeutic implications of Urocortin-2 in Heart Failure with Preserved Ejection Fraction. | YES meeting 16th edition – Young European Scientist Meeting
(Porto, Portugal)
|
| 2021/09 | The role of miR-146a in the pathophysiology of pulmonary arterial hypertension. | YES meeting 16th edition – Young European Scientist Meeting
(Porto, Portugal)
|
| 2021/05/08 | The role of Urocortin-2 in Heart Failure with Preserved Ejection Fraction. | VI Jornadas de Bioquímica
(Porto, Portugal)
|
| 2021/05/07 | Ucns as biomarkers in cardiovascular disease. | IJUP 14th edition - Encontro de Investigação Jovem da Universidade do Porto
(Porto, Portugal)
|
| 2021/05/07 | The role of miR-146a in the pathophysiology of pulmonary arterial hypertension. | IJUP 14th Edition - Encontro de Investigação Jovem da Universidade do Porto.
(Porto, Portugal)
|
Mentoring / Tutoring
| Topic | Student name | |
|---|---|---|
| 2022/09/05 - 2022/09/10 | 16ª Escola de Ciências da Vida e da Saúde - Quando o coração falha: do laboratório à clínica | Maura Silva, Rita Garcia |
Distinctions
Award
| 2022 | AIMS meeting 2022 - Research Competition |